Related Articles
Immune response (IgG) following full inoculation with BNT162b2 COVID‑19 mRNA among healthcare professionals
Nitazoxanide as an early treatment to reduce the intensity of COVID‑19 outbreaks among health personnel
Effects of SARS‑CoV‑2 mRNA vaccines on platelet polyphosphate levels and inflammation: A pilot study
Immune thrombocytopenic purpura induced by the COVID‑19 vaccine after the second dose in a 78‑year‑old patient: A case report
Effectiveness and safety of immune response to SARS‑CoV‑2 vaccine in patients with chronic kidney disease and dialysis: A systematic review and meta‑analysis